Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Impaired vagus-mediated immunosuppression in microsomal prostaglandin E synthase-1 deficient mice.

Le Maître E, Revathikumar P, Idborg H, Raouf J, Korotkova M, Jakobsson PJ, Lampa J.

Prostaglandins Other Lipid Mediat. 2015 May 19. pii: S1098-8823(15)00059-3. doi: 10.1016/j.prostaglandins.2015.05.006. [Epub ahead of print]

PMID:
26001880
2.

MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer.

Olesch C, Sha W, Angioni C, Sha LK, Açaf E, Patrignani P, Jakobsson PJ, Radeke HH, Grösch S, Geisslinger G, von Knethen A, Weigert A, Brüne B.

Oncotarget. 2015 Apr 30;6(12):10284-96.

3.

IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.

Lundström SL, Fernandes-Cerqueira C, Ytterberg AJ, Ossipova E, Hensvold AH, Jakobsson PJ, Malmström V, Catrina AI, Klareskog L, Lundberg K, Zubarev RA.

PLoS One. 2014 Nov 26;9(11):e113924. doi: 10.1371/journal.pone.0113924. eCollection 2014.

4.

Evaluation of urinary prostaglandin E2 metabolite as a biomarker in infants with fever due to viral infection.

Idborg H, Pawelzik SC, Perez-Manso M, Björk L, Hamrin J, Herlenius E, Jakobsson PJ.

Prostaglandins Leukot Essent Fatty Acids. 2014 Dec;91(6):269-75. doi: 10.1016/j.plefa.2014.09.006. Epub 2014 Sep 28.

PMID:
25305792
5.

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, Holmdahl R, Nandakumar KS, Engström M, Harre U, Schett G, Catrina AI, Malmström V, Sommarin Y, Klareskog L, Jakobsson PJ, Lundberg K.

Arthritis Res Ther. 2014 Aug 12;16(4):R167. [Epub ahead of print]

PMID:
25112157
6.

Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.

Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, Haj Hensvold A, Eklund A, Sköld CM, Grunewald J, Malmström V, Jakobsson PJ, Rönnelid J, Padyukov L, Zubarev RA, Klareskog L, Catrina AI.

Ann Rheum Dis. 2014 May 9. doi: 10.1136/annrheumdis-2013-204912. [Epub ahead of print]

PMID:
24817415
7.

Persisting eicosanoid pathways in rheumatic diseases.

Korotkova M, Jakobsson PJ.

Nat Rev Rheumatol. 2014 Apr;10(4):229-41. doi: 10.1038/nrrheum.2014.1. Epub 2014 Feb 11. Review.

PMID:
24514915
8.

Differentially expressed proteins in malignant and benign adrenocortical tumors.

Kjellin H, Johansson H, Höög A, Lehtiö J, Jakobsson PJ, Kjellman M.

PLoS One. 2014 Feb 3;9(2):e87951. doi: 10.1371/journal.pone.0087951. eCollection 2014.

9.

Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins.

Hensvold AH, Magnusson PK, Joshua V, Hansson M, Israelsson L, Ferreira R, Jakobsson PJ, Holmdahl R, Hammarström L, Malmström V, Askling J, Klareskog L, Catrina AI.

Ann Rheum Dis. 2015 Feb;74(2):375-80. doi: 10.1136/annrheumdis-2013-203947. Epub 2013 Nov 25.

PMID:
24276366
10.

Neutralization of anticitrullinated protein antibodies in rheumatoid arthritis - a way to go?

Cerqueira CF, Klareskog L, Jakobsson PJ.

Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):13-7. doi: 10.1111/bcpt.12157. Epub 2013 Nov 11. Review.

PMID:
24206219
11.

Characterization of microsomal prostaglandin E synthase 1 inhibitors.

Korotkova M, Jakobsson PJ.

Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):64-9. doi: 10.1111/bcpt.12162. Epub 2013 Nov 11. Review.

PMID:
24138533
12.

Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation.

Leclerc P, Idborg H, Spahiu L, Larsson C, Nekhotiaeva N, Wannberg J, Stenberg P, Korotkova M, Jakobsson PJ.

Prostaglandins Other Lipid Mediat. 2013 Dec;107:26-34. doi: 10.1016/j.prostaglandins.2013.09.001. Epub 2013 Sep 14.

PMID:
24045148
13.

Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice.

Idborg H, Olsson P, Leclerc P, Raouf J, Jakobsson PJ, Korotkova M.

Prostaglandins Other Lipid Mediat. 2013 Dec;107:18-25. doi: 10.1016/j.prostaglandins.2013.07.004. Epub 2013 Aug 2.

PMID:
23916744
14.

NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis.

Liu HQ, Zhang XY, Edfeldt K, Nijhuis MO, Idborg H, Bäck M, Roy J, Hedin U, Jakobsson PJ, Laman JD, de Kleijn DP, Pasterkamp G, Hansson GK, Yan ZQ.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2193-201. doi: 10.1161/ATVBAHA.113.301715. Epub 2013 Jul 18.

15.

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells.

Zirath H, Frenzel A, Oliynyk G, Segerström L, Westermark UK, Larsson K, Munksgaard Persson M, Hultenby K, Lehtiö J, Einvik C, Påhlman S, Kogner P, Jakobsson PJ, Henriksson MA.

Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10258-63. doi: 10.1073/pnas.1222404110. Epub 2013 Jun 3.

16.

Mass spectrometry-based proteomics identifies UPF1 as a critical gene expression regulator in MonoMac 6 cells.

Ochs MJ, Ossipova E, Oliynyk G, Steinhilber D, Suess B, Jakobsson PJ.

J Proteome Res. 2013 Jun 7;12(6):2622-9. doi: 10.1021/pr301193f. Epub 2013 May 24.

PMID:
23642263
17.

Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis.

Howe LR, Subbaramaiah K, Kent CV, Zhou XK, Chang SH, Hla T, Jakobsson PJ, Hudis CA, Dannenberg AJ.

Prostaglandins Other Lipid Mediat. 2013 Oct;106:99-105. doi: 10.1016/j.prostaglandins.2013.04.002. Epub 2013 Apr 25.

18.

Characterization of a new mPGES-1 inhibitor in rat models of inflammation.

Leclerc P, Pawelzik SC, Idborg H, Spahiu L, Larsson C, Stenberg P, Korotkova M, Jakobsson PJ.

Prostaglandins Other Lipid Mediat. 2013 Apr-May;102-103:1-12. doi: 10.1016/j.prostaglandins.2013.03.005. Epub 2013 Mar 23.

PMID:
23528231
19.

IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts.

Leclerc P, Wähämaa H, Idborg H, Jakobsson PJ, Harris HE, Korotkova M.

Scand J Immunol. 2013 May;77(5):350-60. doi: 10.1111/sji.12041.

20.

Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.

Carlson LM, Rasmuson A, Idborg H, Segerström L, Jakobsson PJ, Sveinbjörnsson B, Kogner P.

Carcinogenesis. 2013 May;34(5):1081-8. doi: 10.1093/carcin/bgt009. Epub 2013 Jan 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk